Catégorie
Levonorgestrel
Numéro CAS
100021-05-4
Formule moléculaire
C21H28O2
Masse moléculaire
312.45
Pureté

Not less than-95.0%

Synonyme

13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-5-en-20-yn-3-one; 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel; (17α)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one; Levonorgestrel-5-ene isomer; 13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-5-en-20-yn-3-one; (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one; (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-4,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

Mots-clés
Fine Chemicals
Intermediates
Pharmaceutical Standards
Impurities
Levonorgestrel EP Impurity P

Levonorgestrel EP Impurity P is a listed impurity in the European Pharmacopoeia for levonorgestrel. It is used as a reference standard in HPLC and other analytical techniques for impurity profiling, method validation, and stability studies. Monitoring this impurity ensures the purity, safety, and regulatory compliance of levonorgestrel active pharmaceutical ingredients (APIs) and finished dosage forms.